In his interesting review, Joo H. Kang (BioChip Journal, 2020) writes about ingenious approaches that address the unmet needs in sepsis treatment. He explicitly mentions hemotune performing pioneer work in the field of magnetic nanoparticle assisted blood cleansing devices. According to Kang, this revolutionary technology bears great potential for the successful removal of toxic molecules in a patient’s blood stream. This could have a significant positive impact on the outcome of sepsis and additionally, reduce the mortality rate (1). Sepsis is a dysregulated immune response to infection with globally 11 million deaths annually. Its most severe form septic shock has mortality rates of 30-50%

The answer is a qualified “yes”. On March 13, the World Health Organization (WHO) published a guide line document with detailed instructions on the clinical management in case an infection with SARS-CoV-2 is suspected, also known as the novel coronavirus (1). The guide line lists sepsis as a possible cause of death among COVID-19 patients. Another interesting article that highlights the connection between COVID-19 and sepsis was published in Nursing Times, on March 10 (2). Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to an infection and can be triggered by a variety of pathogens, including SARS-CoV-2. Unfortunately, sepsis is often diagnosed very late